Brief: Scopus Biopharma Unit Duet Therapeutics Releases Preclinical Data At 17Th Annual Meeting Of Oligonucleotide Therapeutics Society
29/09/2021 13:50
Sept 29 (Reuters) - Scopus Biopharma Inc SCPS.O :
* SCOPUS BIOPHARMA UNIT DUET THERAPEUTICS ANNOUNCES RELEASE
OF
PRECLINICAL DATA AT 17TH ANNUAL MEETING OF OLIGONUCLEOTIDE
THERAPEUTICS SOCIETY
* SCOPUS BIOPHARMA INC - DATA BENCHMARK DUET'S BIFUNCTIONAL
OLIGONUCLEOTIDES AGAINST IMMUNE CHECKPOINT INHIBITORS IN
LYMPHOMA, PROSTATE TUMOR IN MICE
Source text for Eikon: ID:nGNX7Wnt77
Further company coverage: SCPS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scopus Biopharma
See all newsBrief: Scopus Biopharma - Nasdaq Hearings Panel Informed Company, By Letter Dated December 15, Of Its Determination To Delist Co's Common Stock From Nasdaq
Brief: Scopus Biopharma Completes Recapitalization To Enhance Shareholder Value
Brief: Scopus Biopharma Says Received Additional Non-Compliance Letter From Nasdaq
Brief: Scopus Biopharma Received Deficiency Letter From Nasdaq
Brief: Scopus BioPharma Inc- On April 4, Received Deficiency Notification Letter From Nasdaq Indicating Co Was Not In Compliance With Nasdaq Listing Rule